AT VANQUISH, WE ARE

CONSTANTLY EVOLVING

AT VANQUISH, WE ARE
CONSTANTLY EVOLVING

  • Providing and constantly looking for innovative solutions to improve our health care system.
  • Helping Mexican families with access to effective and safe treatments.
  • Committed to continuously enhancing the Vanquish community: We strive to have a positive impact on our staff, business associates, and other key partners.
 
  • Providing and constantly looking for innovative solutions to improve our health care system.
  • Helping Mexican families with access to effective and safe treatments.
  • Committed to continuously enhancing the Vanquish community: We strive to have a positive impact on our staff, business associates, and other key partners.

FOCUS

Making a difference in the lives of patients and their families, as well as our employees, business partners, and investors.

PURPOSE

Our slogan “valoramos la vida cuidando tu salud” expresses our commitment best: We are improving the lives of our patients, employees, and stakeholders.

O U R   H I S T O R Y

OUR

HISTORY

 

In 1979, we started as an API development and manufacturing company (active ingredients / raw material). It means a pharmacochemical laboratory for the pharmaceutical industry. Throughout four decades of experience, we have constantly grown and evolved to consolidate ourselves as Vanquish Group.

 

We opened our first plant in Civac, Morelos.


Development and manufacturing of active ingredients for the pharmaceutical industry.
1979 - 1990


We innovated with the development and patenting of the active ingredient
Calcium Gluconolactate, used to treat osteoporosis.
2002
We established ourselves as a pharmaceutical company
active in both, private and public sector.
2004
Grupo Vanquish consolidated, with products and services
tailored to address the diverse requirements
of the healthcare sector.
2017
Entering the international market, continuing to build
and expand our portfolio of high-quality products and services.
2019 - 2024
By 2030, we aim to broaden our strategic sectors
and rank among the top five healthcare enterprises
with a notable footprint in Latin America.
2025 - 2030 What comes next?

1979-1990

  • We opened our first plant in Civac, Morelos.
  • Development and manufacturing of active ingredients for the pharmaceutical industry.

2002

  • We innovated with the development and patenting of the active ingredient Calcium Gluconolactate, used to treat osteoporosis.

2004

  • We established ourselves as a pharmaceutical company active in both, private and public sector.

2017

  • Grupo Vanquish consolidated, with products and services tailored to address the diverse requirements of the healthcare sector.

2019 - 2024

  • Entering the international market, continuing to build and expand our portfolio of high-quality products and services.

2025-2030

  • What comes next? By 2030, we aim to broaden our strategic sectors and rank among the top five healthcare enterprises with a notable footprint in Latin America.